Gender differences in cardiotoxicities associated with immune checkpoint inhibitor therapy in cancer patients

Background: Immune checkpoint inhibitors (ICIs) are increasingly being used for cancer therapy. Cardiotoxicity from ICIs has largely been underestimated since cardiovascular monitoring is not routinely performed after initiating immunotherapy. Cardiotoxic side effects are uncommon but are serious co...

Full description

Bibliographic Details
Main Authors: Sheharyar Minhas, Ahmed Minhas, Maira Malik
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Journal of Clinical and Preventive Cardiology
Subjects:
Online Access:http://www.jcpconline.org/article.asp?issn=2250-3528;year=2020;volume=9;issue=2;spage=73;epage=77;aulast=Minhas